Rafina Innovations, Inc. (VICA)
| Market Cap | 718,390 |
| Revenue (ttm) | 335,150 |
| Net Income (ttm) | -5.78M |
| Shares Out | 15.72M |
| EPS (ttm) | -0.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 1 |
| Last Price | $0.0457 |
| Previous Close | $0.0373 |
| Change ($) | 0.0084 |
| Change (%) | 22.52% |
| Day's Open | 0.0457 |
| Day's Range | 0.0457 - 0.0457 |
| Day's Volume | 0 |
| 52-Week Range | 0.0013 - 0.098 |
News
There are no news available yet.
About VICA
Rafina Innovations engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabeti... [Read more...]
| Industry Medical Devices | Founded 2007 |
| CEO Constantinos Zertalis | Employees 4 |
| Stock Exchange OTCMKTS | Ticker Symbol VICA |
Financial Performance
In 2018, VICA's revenue was $412,682, an increase of 16.01% compared to the previous year's $355,736. Losses were -$5.85 million, 95.8% more than in 2017.